Neuroimaging to predict preclinical Alzheimer's disease

被引：2
|
作者：
Kumari, V
Mitterschiffthaler, MT
Sharma, T
机构：
[1] Inst Psychiat, Div Psychol Med, Sect Cognit Psychopharmacol, London SE5 8AF, England
[2] Inst Psychiat, Dept Psychol, London SE5 8AF, England
[3] Stonehouse Hosp, Res Ctr, Dartford, Kent, England
来源：
HOSPITAL MEDICINE | 2002年 / 63卷 / 06期
关键词：
D O I：
10.12968/hosp.2002.63.6.2004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Alzheimer's disease is common in the elderly and causes tremendous distress to patients and their carers. With the advent of newer pharmacological treatments, significant improvement in the early diagnosis of Alzheimer's disease is required. This article examines the usefulness of neuroimaging techniques to predict Alzheimer's disease in prediagnosis individuals.
引用
收藏
页码：341 / 345
页数：5
相关论文
共 50 条
  • [1] Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease
    Twamley, Elizabeth W.
    Ropacki, Susan A. Legendre
    Bondi, Mark W.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2006, 12 (05) : 707 - 735
  • [2] Multimorbidity Is Associated with Preclinical Alzheimer's Disease Neuroimaging Biomarkers
    Mendes, Aline
    du Montcel, Sophie Tezenas
    Levy, Marcel
    Bertrand, Anne
    Habert, Marie-Odile
    Bertin, Hugo
    Dubois, Bruno
    Epelbaum, Stephane
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2018, 45 (5-6) : 272 - 281
  • [3] Empirically defining the preclinical stages of the Alzheimer's continuum in the Alzheimer's Disease Neuroimaging Initiative
    Kiselica, Andrew M.
    PSYCHOGERIATRICS, 2021, 21 (04) : 491 - 502
  • [4] Neuroimaging in Alzheimer's disease: preclinical challenges toward clinical efficacy
    Dustin, Derek
    Hall, Benjamin M.
    Annapragada, Ananth
    Pautler, Robia G.
    TRANSLATIONAL RESEARCH, 2016, 175 : 37 - 53
  • [5] Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer's disease
    Ng, Kok Pin
    Pascoal, Tharick A.
    Mathotaarachchi, Sulantha
    Chung, Chang-Oh
    Benedet, Andrea L.
    Shin, Monica
    Kang, Min Su
    Li, Xiaofeng
    Ba, Maowen
    Kandiah, Nagaendran
    Rosa-Neto, Pedro
    Gauthier, Serge
    NEUROLOGY, 2017, 88
  • [6] Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease
    Wang, Xiaoqi
    Huang, Weijie
    Su, Li
    Xing, Yue
    Jessen, Frank
    Sun, Yu
    Shu, Ni
    Han, Ying
    MOLECULAR NEURODEGENERATION, 2020, 15 (01)
  • [7] Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
    Xiaoqi Wang
    Weijie Huang
    Li Su
    Yue Xing
    Frank Jessen
    Yu Sun
    Ni Shu
    Ying Han
    Molecular Neurodegeneration, 15
  • [8] Preclinical Detection of Alzheimer's Disease Using Neuroimaging: The Influence of Risk and Reserve
    Nielson, K. A.
    JOURNAL OF PSYCHOPHYSIOLOGY, 2011, 25 : 23 - 23
  • [9] Neuroimaging in Alzheimer's disease
    Fox, N. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S197 - S198
  • [10] Alzheimer's disease neuroimaging
    Whitwell, Jennifer L.
    CURRENT OPINION IN NEUROLOGY, 2018, 31 (04) : 396 - 404
12345